Menu Search
Equities

Tinavi Medical Technologies Co Ltd

688277:SHH

Tinavi Medical Technologies Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)10.61
  • Today's Change-0.49 / -4.41%
  • Shares traded6.64m
  • 1 Year change-26.88%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Tinavi Medical Technologies Co Ltd had net income fall 41.42% from a loss of 110.58m to a larger loss of 156.39m despite a 34.48% increase in revenues from 156.19m to 210.04m. An increase in the selling, general and administrative costs as a percentage of sales from 94.12% to 99.07% was a component in the falling net income despite rising revenues.
Gross margin68.66%
Net profit margin-95.24%
Operating margin-87.70%
Return on assets-10.24%
Return on equity-12.84%
Return on investment-11.04%
More ▼

Cash flow in CNYView more

In 2023, Tinavi Medical Technologies Co Ltd increased its cash reserves by 47.10%, or 99.47m. Cash Flow from Financing totalled 528.30m or 251.53% of revenues. In addition the company used 170.50m for operations while cash used for investing totalled 258.17m.
Cash flow per share--
Price/Cash flow per share--
Book value per share2.62
Tangible book value per share2.56
More ▼

Balance sheet in CNYView more

Tinavi Medical Technologies Co Ltd has a Debt to Total Capital ratio of 15.32%, a higher figure than the previous year's 12.59%.
Current ratio2.46
Quick ratio2.21
Total debt/total equity0.1809
Total debt/total capital0.1532
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.